American Healthcare REIT, Inc.

American Healthcare REIT, Inc.

AHR·NYSE

$46.59

-0.56%
Real EstateREIT - Healthcare Facilities

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.

At a Glance

Live Snapshot
Market Cap$9.63B
EPS0.4200
P/E Ratio111.95
Earnings Date08/06/2026
ahr

American Healthcare REIT, Inc. Street Expectations Map

AHR · NYSE

Wall Street analysts project that AHR stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 57.20, with estimates ranging from a low of 55.00 to a high of 60.00.

Lowest Target
55.00
18.05%
Consensus Target
57.20
22.77%
Highest Target
60.00
28.78%

The consensus 1-year price target stands at 57.20, with estimates ranging from a low of 55.00 to a high of 60.00.

Analyst Consensus Analysis

Upside Potential

+22.8%

Strong upside potential. Consensus indicates attractive return opportunity with favorable risk-reward profile.

Analyst Agreement

8.7% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

ahr

American Healthcare REIT, Inc. Forward Estimates of Revenue

AHR · NYSE
Latest Revenue
2.26B
FY 2025
Avg Estimate
2.64B
FY 2026
Estimate Range
2.59B - 2.81B
Analyst Spread

Forward Growth Analysis

Projected Growth+16.8%

Solid growth trajectory indicates healthy business performance and competitive positioning.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread8%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

ahr

American Healthcare REIT, Inc. Forward Estimates of Net Income

AHR · NYSE
Latest Net Income
69.81M
FY 2025
Avg Estimate
95.29M
FY 2026
Estimate Range
93.68M - 96.91M
Analyst Spread

Forward Growth Analysis

Projected Growth+36.5%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread3%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

ahr

American Healthcare REIT, Inc. Forward Estimates of EPS

AHR · NYSE
Latest EPS
0.42
FY 2025
Avg Estimate
$0.57
FY 2026
Estimate Range
$0.56 - $0.58
Analyst Spread

Forward Growth Analysis

Projected Growth+35.7%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage3 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread3%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

ahr

American Healthcare REIT, Inc. Forward Estimates of EBIT

AHR · NYSE
Latest EBIT
134.42M
FY 2025
Avg Estimate
324.04M
FY 2026
Estimate Range
317.77M - 344.89M
Analyst Spread

Forward Growth Analysis

Projected Growth+141.1%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread8%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

ahr

American Healthcare REIT, Inc. Forward Estimates of EBITDA

AHR · NYSE
Latest EBITDA
321.98M
FY 2025
Avg Estimate
428.42M
FY 2026
Estimate Range
420.13M - 455.99M
Analyst Spread

Forward Growth Analysis

Projected Growth+33.1%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread8%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

ahr

American Healthcare REIT, Inc. Forward Estimates of SG&A Expense

AHR · NYSE
Latest SG&A Expense
0.00
FY 2025
Avg Estimate
107.17M
FY 2026
Estimate Range
105.10M - 114.07M
Analyst Spread

Forward Growth Analysis

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread8%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

ahr

American Healthcare REIT, Inc. Insider Positioning

AHR · NYSE

During the last 12 months, insiders have sold $4.12M worth of AHR shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

2.0K

97.10K

Net Activity

-97K

-$97K

3-6 Months

Bought

0

0.00

Sold

54.8K

2.65M

Net Activity

-2.7M

-$2.65M

6-9 Months

Bought

0

0.00

Sold

21.5K

1.07M

Net Activity

-1.1M

-$1.07M

9-12 Months

Bought

0

0.00

Sold

7.7K

300.62K

Net Activity

-301K

-$301K

Top Buyers

No buying activity

Top Sellers

1
HJT

Hanson Jeffrey T

Director

74.8K shares3 transactions

$3.64M

2
FME

Foster Mark E.

Officer: Evp, Gc & Secretary

7.3K shares3 transactions

$332K

3
OSK

Oh Stefan K.L.

Officer: Chief Investment Officer

3.9K shares1 transactions

$139K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $4.12M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$97K

Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.

Insider Participation

High Selling

3 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.